Do Not Stop Anti-TNF Medications in Children With IBD When They Are Working

Inflamm Bowel Dis. 2022 Feb 1;28(2):322-324. doi: 10.1093/ibd/izab047.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Adalimumab / therapeutic use
  • Child
  • Humans
  • Inflammatory Bowel Diseases* / drug therapy
  • Infliximab / therapeutic use
  • Tumor Necrosis Factor Inhibitors* / therapeutic use

Substances

  • Tumor Necrosis Factor Inhibitors
  • Infliximab
  • Adalimumab